Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre
CAMBRIDGE, UK, AND STEVENAGE, UK: Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, announces a collaboration to demonstrate universal automation of CGT manufacturing.
The partnership will undertake the physical and digital integration of existing bioprocessing equipment at the CGT […]
Full Post at www.cambridgenetwork.co.uk